Iron Overload in Patients with Acute Leukemia or MDS Undergoing Myeloablative Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 6, 2011, Pages 852-860

  Armand, Philippe ^a   Kim, Haesook T ^a   Rhodes, Joanna ^b   Sainvil, Marie Michele ^a   Cutler, Corey ^a   Ho, Vincent T ^a   Koreth, John ^a   Alyea, Edwin P ^a   Hearsey, Doreen ^a   Neufeld, Ellis J ^c   Fleming, Mark D ^c   Steen, Hanno ^c   Anderson, Damon ^c   Kwong, Raymond Y ^d   Soiffer, Robert J ^a   Antin, Joseph H ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acute lymphoblastic leukemia; Acute myeloid leukemia; Iron overload; Myelodysplastic syndromes; Stem cell transplantation

Indexed keywords

FERRITIN; HEPCIDIN;

ACUTE LEUKEMIA; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FERRITIN BLOOD LEVEL; HEART; HUMAN; IRON OVERLOAD; LIVER; MALE; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; STEM CELL TRANSPLANTATION;

ANTIMICROBIAL CATIONIC PEPTIDES; FERRITINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IRON; IRON OVERLOAD; LEUKEMIA, MYELOID, ACUTE; LIVER; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 79956044464     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.09.006     Document Type: Article

References (31)

1. Alessandrino E.P., Della Porta M.G., Bacigalupo A., et al. Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica 2010, 95:476-484.
2. Altes A., Remacha A.F., Sureda A., et al. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant 2002, 29:987-989.
3. Armand P., Kim H.T., Cutler C.S., et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007, 109:4586-4588.
4. Kataoka K., Nannya Y., Hangaishi A., et al. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009, 15:195-204.
5. Lee J.W., Kang H.J., Kim E.K., Kim H., Shin H.Y., Ahn H.S. Effect of iron overload and iron-chelating therapy on/allogeneic hematopoietic SCT in children. Bone Marrow Transplant 2009, 44:793-797.
6. Mahindra A., Bolwell B., Sobecks R., et al. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation. Br J Haematol 2009, 146:310-316.
7. Platzbecker U., Bornhauser M., Germing U., et al. Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS). Biol Blood Marrow Transplant 2008, 14:1217-1225.
8. Pullarkat V., Blanchard S., Tegtmeier B., et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2008, 42:799-805.
9. Storey J.A., Connor R.F., Lewis Z.T., et al. The transplant iron score as a predictor of stem cell transplant survival. J Hematol Oncol 2009, 2:44.
10. Kim Y.R., Kim J.S., Cheong J.W., Song J.W., Min Y.H. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies. Acta Haematol 2008, 120:182-189.
11. Lim Z.Y., Fiaccadori V., Gandhi S., et al. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation. Leuk Res 2009, 34:723-727.
12. Morado M., Ojeda E., Garcia-Bustos J., et al. BMT: serum ferritin as risk factor for veno-occlusive disease of the liver. Prospective Cohort Study. Hematology 2000, 4:505-512.
13. Maradei S.C., Maiolino A., de Azevedo A.M., Colares M., Bouzas L.F., Nucci M. Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. Blood 2009, 114:1270-1275.
14. Lee S.H., Yoo K.H., Sung K.W., et al. Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Bone Marrow Transplant 2010, 45:1287-1293.
15. Kontoyiannis D.P., Chamilos G., Lewis R.E., et al. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer 2007, 110:1303-1306.
16. Ozyilmaz E., Aydogdu M., Sucak G., et al. Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload. Bone Marrow Transplant 2010 Oct, 45(10):1528-1533.
17. Cutler C., Li S., Ho V.T., et al. Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation. Blood 2007, 109:3108-3114.
18. Anderson D.S., Heeney M.M., Roth U., Menzel C., Fleming M.D., Steen H. High-throughput matrix-assisted laser desorption ionization-time-of-flight mass spectrometry method for quantification of hepcidin in human urine. Anal Chem 2010, 82:1551-1555.
19. Westwood M., Anderson L.J., Firmin D.N., et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003, 18:33-39.
20. Wood J.C., Enriquez C., Ghugre N., et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005, 106:1460-1465.
21. Rosner B., Willett W.C., Spiegelman D. Correction of logistic regression relative risk estimates and confidence intervals for systematic within-person measurement error. Stat Med 1989, 8:1051-1069. discussion 1071-1053.
22. Spiegelman D., McDermott A., Rosner B. Regression calibration method for correcting measurement-error bias in nutritional epidemiology. Am J Clin Nutr 1997, 65:1179S-1186S.
23. Hankins J.S., McCarville M.B., Loeffler R.B., et al. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood 2009, 113:4853-4855.
24. Emond M.J., Bronner M.P., Carlson T.H., Lin M., Labbe R.F., Kowdley K.V. Quantitative study of the variability of hepatic iron concentrations. Clin Chem 1999, 45:340-346.
25. Olivieri N.F., Brittenham G.M. Iron-chelating therapy and the treatment of thalassemia. Blood 1997, 89:739-761.
26. Noetzli L.J., Carson S.M., Nord A.S., Coates T.D., Wood J.C. Longitudinal analysis of heart and liver iron in thalassemia major. Blood 2008, 112:2973-2978.
27. Sahlstedt L., von Bonsdorff L., Ebeling F., Parkkinen J., Juvonen E., Ruutu T. Non-transferrin-bound iron in haematological patients during chemotherapy and conditioning for autologous stem cell transplantation. Eur J Haematol 2009, 83:455-459.
28. Ganz T., Olbina G., Girelli D., Nemeth E., Westerman M. Immunoassay for human serum hepcidin. Blood 2008, 112:4292-4297.
29. Zhang A.S., Enns C.A. Molecular mechanisms of normal iron homeostasis. Hematology Am Soc Hematol Educ Program 2009, 207-214.
30. Alexopoulou E., Stripeli F., Baras P., et al. R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients. J Magn Reson Imaging 2006, 23:163-170.
31. Alessandrino E.P., Della Porta M.G., Bacigalupo A., et al. Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Haematologica 2010 Mar, 95(3):476-484.